SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-095513
Filing Date
2021-07-26
Accepted
2021-07-23 18:22:40
Documents
13
Period of Report
2021-07-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123159d1_8k.htm   iXBRL 8-K 24305
2 EXHIBIT 99.1 tm2123159d1_ex99-1.htm EX-99.1 7589
  Complete submission text file 0001104659-21-095513.txt   210966

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hepa-20210723.xsd EX-101.SCH 3182
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20210723_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20210723_pre.xml EX-101.PRE 22708
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2123159d1_8k_htm.xml XML 3696
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 211111858
SIC: 2834 Pharmaceutical Preparations